Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645658 · ClinicalTrials.gov registry record · NA
Testosterone Replacement Therapy in Advanced Chronic Kidney Disease
A NA study, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00645658 is a NA study that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 17 participants.
The verdict
NCT00645658, a NA study, has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Muscle wasting is common in advanced chronic kidney disease (CKD) and adversely affects morbidity and mortality. In 2/3 of males with advanced CKD serum testosterone (TT) levels are reduced, and likely contributes to the wasting. As TT in relatively safe physiologic replacement doses, increases muscle mass in otherwise normal TT deficient subjects, we hypothesize that physiologic TT replacement will be effective in preventing and treating the loss of muscle mass and function in CKD patients, will improve quality of life and may reduce some cardiovascular disease (CVD) risk factors.
Interventions
- DRUG Testim, 1% testosterone gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00645658
The ClinicalTrials.gov registry entry for NCT00645658 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testim, 1% testosterone gel is the first listed.
NCT00645658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00645658 about?
NCT00645658 is a clinical study titled "Testosterone Replacement Therapy in Advanced Chronic Kidney Disease". Muscle wasting is common in advanced chronic kidney disease (CKD) and adversely affects morbidity and mortality. In 2/3 of males with advanced CKD serum testosterone (TT) levels are reduced, and likely contributes to the wasting. As TT in relatively safe physiologic replacement doses, increases musc...
What is the current status of trial NCT00645658?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2007-08. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00645658?
The interventions under investigation include: Testim, 1% testosterone gel (DRUG).
Who is sponsoring clinical trial NCT00645658?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.